ELAVL1 and liver cancer: The overexpression of WTAP in liver cancer contributes to the m6A modification of ETS1 mRNA, followed by apparent silencing of ETS1 in a HuR-related manner through the HuR-ETS1-p21/p27 axis, regulation of the G2/M phase, and increased progression [24].